Danial Namazi completed his pre-medical studies at Philipps-Universität Marburg and concluded his medical education at the University of Lübeck. In June 2024, he joined the Lübeck Institute of Experimental Dermatology as a M.D. candidate, focusing on investigating the effects of kinase inhibitors in the human skin organ culture (HSOC) model of pemphigus foliaceus.